Results · Apr-Jun 2026 · filed 14 Aug 2026
Ambar Protein Industries Q1 FY27 results
Sales fell 3% to ₹113 crore from ₹117 crore in Apr-Jun 2025.
Operating profit grew 168% to ₹5.8 crore, an operating margin of 5.1% (up 3.2 points from a year ago).
Net profit grew 402% to ₹3.8 crore from ₹0.75 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −23%, net profit +52%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 113.4 | 117.3 | −3% |
| Operating profit (EBITDA) | 5.8 | 2.1 | +168% |
| Operating margin | 5.1% | 1.8% | +3.2 pts |
| Net profit | 3.8 | 0.7 | +402% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 18 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026Result Un Audited Financial Result For Quarter Ended June 30, 2026
- 14 Aug 2026Board Meeting Outcome for OUTCOME OF BOARD MEETING
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.